Mikfetin^® Fito (Syrup) Instructions for Use

Marketing Authorization Holder

Moscow Pharmaceutical Factory CJS (Russia)

ATC Code

R05CA (Expectorants)

Dosage Form

Mikfetin® Fito

Syrup 12 g+1 g/100 g: bottle 100 g or 125 g

Dosage Form, Packaging, and Composition

100 g – dark glass bottles (1) – cardboard packs.
125 g – dark glass bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Herbal preparation with expectorant, antimicrobial, and bronchodilatory action

Pharmacotherapeutic Group

Drugs used for cough and colds; expectorants, excluding combinations with antitussives; expectorants

Pharmacological Action

A combined herbal preparation.

Thyme herb has an expectorant effect, increases the amount of secretory discharge from the mucous membrane of the upper respiratory tract, promotes sputum thinning and accelerates its elimination. Potassium bromide reduces the excitability of the central nervous system.

Indications

• Use as an expectorant for symptomatic treatment of cough associated with acute respiratory infections.
• Administer for inflammatory conditions of the respiratory tract, including tracheitis and bronchitis.
• Employ as part of the therapeutic regimen for whooping cough.

ICD codes

Dosage Regimen

Administer orally three times daily. For adults, use a dose of one tablespoon per administration.

For pediatric patients, adjust the dose according to age: administer from half a teaspoon to one dessert spoon per dose. Adhere strictly to the three-times-daily schedule.

Adverse Reactions

Monitor for signs of hypersensitivity, including various allergic reactions.

Observe for gastrointestinal disturbances, most notably heartburn. Discontinue use if adverse reactions are severe or persistent.

Drug Interactions

Exercise caution due to the presence of potassium bromide, which may interact with other central nervous system depressants, potentially enhancing sedative effects.

Avoid concurrent use with drugs that may increase bromide levels or potentiate its toxicity. Consult full prescribing information for a comprehensive list of potential interactions.

Contraindications

• Do not use in patients with known hypersensitivity to any component of the formulation.
• Contraindicated in patients with decompensated chronic heart failure.
• Strictly avoid use during pregnancy and throughout the lactation period.

Overdose

In case of overdose, manifestations may include gastrointestinal distress and signs of bromism due to potassium bromide content.

Symptoms of bromism can encompass drowsiness, ataxia, and skin rashes. Immediately discontinue the medication and institute supportive and symptomatic treatment; consider gastric lavage if ingestion is recent.

Use in Pregnancy and Lactation

Contraindicated during pregnancy and lactation.

Pediatric Use

For children (depending on age) – from 1/2 teaspoon to 1 dessert spoon 3 times a day.

Special Precautions

The syrup contains sugar, which should be taken into account by patients with concomitant diabetes mellitus.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.